Neuroinflammation represents a hallmark of many degenerative diseases, such as Alzheimer’s Disease, Parkinson’s Disease, amyotrophic lateral sclerosis, multiple sclerosis, multiple system atrophy and ...

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for ...

After years of misdiagnosis, Rod Fussinger was finally diagnosed with Anti-IgLON5 Associated Autoimmune Encephalitis, and ...

Since taking over as CEO of the Cambridge biotech more than three years ago, Chris Viehbacher has cut hundreds of jobs and reduced expenses, in part by removing drugs from its research pipeline.

ProMIS Neurosciences, Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing next-generation therapies for Alzheimer's disease ...

ZipBio, a biotechnology company pioneering AI-driven protein therapeutics, announced an exclusive license agreement with MeiraGTx Holdings plc , a vertically integrated, clinical-stage genetic ...

Molecular imaging is redefining in vivo characterization of multiple sclerosis, a demyelinating disease with complex and heterogeneous clinical profiles. Recent advances in PET tracers enable more ...

The UAE is rapidly consolidating its position as a global pharmaceutical and life sciences hub, with the national market ...

After witnessing my father’s tortuous battle with the illness I wanted to understand my own risk, so I visited a brain expert ...

Seasoned clinical development leader brings more than 25 years of deep expertise in clinical development and operations across biotech and ...

Lester Eugene Hughes died peacefully at home on Sunday, December 21, 2025, after suffering several years from the neurological disease ...

Read about the backgrounds and research interests of team members in Dr. Grinberg's Neurodegeneration and Sleep Pathology Lab at Mayo Clinic.